首页|非小细胞肺癌患者血清miR-873和miR-138-5p表达水平及其与免疫微环境及预后的相关性分析

非小细胞肺癌患者血清miR-873和miR-138-5p表达水平及其与免疫微环境及预后的相关性分析

扫码查看
目的 探讨血清微小核糖核酸(micro RNA,miRNAs)-873 和微小核糖核酸-138-5p表达与非小细胞肺癌(non-small cell lung cancer,NSCLC)患者肿瘤免疫微环境(tumor immune microenvironment,TIME)以及预后的关系.方法 选择 2019 年 2 月~2021 年 2 月重庆医科大学附属巴南医院收治的 108 例NSCLC患者(NSCLC组)和 65例门诊体检的健康志愿者(对照组).实时荧光定量聚合酶链反应检测血清miR-873 和miR-138-5p表达,多重免疫荧光染色法检测TIME指标,出院后定期随访.Pearson分析血清miR-873 和miR-138-5p表达与TIME指标的相关性,Kaplan-Meier和COX比例风险回归分析miR-873,miR-138-5p与NSCLC患者预后的关系.结果 与对照组比较,NSCLC组血清miR-873(1.02±0.23 vs 3.15±0.82)和miR-138-5p(1.21±0.26 vs 3.54±0.92)表达降低,差异具有统计学意义(t=-25.426,-24.769,均P<0.05).TNM分期Ⅲ~Ⅳ期、低中度分化患者血清miR-873 和miR-138-5p表达低于TNM分期Ⅰ~Ⅱ期、高度分化患者(t=9.615,10.253;6.889,3.361,均P<0.05).血清miR-873,miR-138-5p表达与PD-1,PD-L1,CD4 和CD8 H值呈负相关(r=-0.418~-0.673,均P<0.05).低表达miR-873 和miR-138-5p的NSCLC患者OS生存率低于高表达miR-873和miR-138-5p的NSCLC患者(Log-Rankχ2=4.724,5.607,P<0.05).TNM分期Ⅲ~Ⅳ期是NSCLC患者不良预后的危险因素(P<0.05),miR-873,miR-138-5p是保护因素(P<0.05).结论 NSCLC患者血清miR-873和miR-138-5p表达下调,且与TIME以及低生存率有关.
Analysis of the Relationship between Serum miR-873 and miR-138-5p Expression and Immune Microenvironment and Prognosis in Patients with Non-small Cell Lung Cancer
Objective To investigate the relationship between serum micro RNA(miRNAs)-873 and micro RNA-138-5p expression and tumor immune microenvironment(TIME)and prognosis in patients with non-small cell lung cancer(NSCLC).Methods A total of 108 NSCLC patients(NSCLC group)and 65 healthy volunteers(control group)who were admitted to Ba'nan Hospital Affiliated to Chongqing Medical University from February 2019 to February 2021 were selected.Real-time quantitative fluorescence polymeric chain reaction(qRT-PCR)was used to detect the expression of miR-873 and miR-138-5p in serum,and multiple immunofluorescence staining was used to detect tumor immune microenvironment indicators.Regular follow-up was conducted after discharge.Pearson analyzed the correlation between the expression of miR-873 and miR-138-5p in serum and the TIME index,and Kaplan-Meier and COX proportional risk regression analyzed the relationship between miR-873 and miR-138-5p and the prognosis of NSCLC patients.Results Comparison with control group,the expressions of miR-873(1.02±0.23 vs 3.15±0.82)and miR-138-5p(1.21±0.26 vs 3.54±0.92)in serum of NSCLC group were decreased,and the differences were statistically significant(t=-25.426,-24.769,all P<0.05).The expressions of serum miR-873 and miR-138-5p of patients with low-to-moderate differentiation in TNM stages Ⅲ to Ⅳ were lower than those with highly differentiated patients in TNM stages Ⅰ to Ⅱ(t=9.615,10.253;6.889,3.361,all P<0.05).The expressions of miR-873 and miR-138-5p in serum were negatively correlated with the values of PD-1,PD-L1,CD4 and CD8 H(r=-0.418~-0.673,all P<0.05).The OS survival rate of NSCLC patients with low expression of miR-873 and miR-138-5p was lower than that of those with high expression of miR-873 and miR-138-5p(Log-Rankχ2=4.724,5.607,P<0.05).TNM stage Ⅲ~Ⅳ was a risk factor for poor prognosis in patients with NSCLC(P<0.05),and miR-873 and miR-138-5p were protective factors(P<0.05).Conclusion The expressions of miR-873 and miR-138-5p in serum of NSCLC patients are down-regulated,which is related to TIME and low survival rate.

non-small cell lung cancertumor immune microenvironmentmicro RNA-873micro RNA-138-5p

刘捷、杨玲玲、程秋霞、高瞻

展开 >

重庆医科大学附属巴南医院呼吸与危重症医学科,重庆 400054

陆军军医大学第二附属医院呼吸与危重症医学科,重庆 400037

非小细胞肺癌 肿瘤免疫微环境 微小核糖核酸-873 微小核糖核酸-138-5p

重庆市巴南区科学技术科研项目

2021-41

2024

现代检验医学杂志
陕西省临床检验中心,陕西省人民医院

现代检验医学杂志

CSTPCD
影响因子:0.713
ISSN:1671-7414
年,卷(期):2024.39(1)
  • 3